2025年美国妇科肿瘤学会年会（2025 SGO ANNUAL MEETING ON WOMEN’S CANCER） 于2025年3月14-17日在美国西雅图隆重召开。大会已公布详细日程及研究题目，其中多达33项中国科研成果成功入选。【肿瘤资讯】全面梳理了科学全体会议（Scientific Plenary）、焦点论坛（Focused Forum）、特色壁报专场（Featured Poster Session）、壁报导览（Poster Tour）和手术影片（Surgical Films）中的中国成果信息，为您呈现中国妇科肿瘤领域的前沿进展，不容错过。
科学全体会议（Scientific Plenary）
专场标题：Scientific Plenary I: IMPACTful Trials: Improving Patient Care
英文标题：Cadonilimab plus lenvatinib in patients with advanced endometrial cancer: a multicenter, single-arm, phase II trial
中文标题：卡度尼利单抗+仑伐替尼治疗晚期子宫内膜癌患者：一项多中心、单臂、I期临床试验
汇报人：蓝春燕丨中山大学肿瘤防治中心
专场标题：Scientific Plenary I: IMPACTful Trials: Improving Patient Care
英文标题：Sentinel Lymph Node Biopsy versus Pelvic Lymphadenectomy in Cervical Cancer: the PHENIX-I trial
中文标题：宫颈癌SLNB vs 盆腔淋巴结清扫术：PHENIX-I试验
汇报人：刘继红丨中山大学肿瘤防治中心
专场标题：Scientific Plenary III: Race for IMPACT: Late Breaking Abstracts
英文标题：Comparing Efficacy and Safety of Biweekly Single-Dose Actinomycin D versus Multiday Methotrexate Therapy in Low-Risk Gestational Trophoblastic Neoplasia: A Prospective Multicentre Randomized Trial
中文标题：每两周单剂量放线菌素D vs 多日甲氨蝶呤治疗低风险妊娠滋养细胞癌的疗效和安全性：一项前瞻性多中心随机试验
汇报人：蒋芳丨北京协和医院
焦点论坛（Focused Forum）
专场标题：Focused Forum II: Improving Cervical Cancer Care: Expanding on What’s Old and Quickly Implementing What’s New (Cervical Cancer Taskforce)
英文标题：Zimberelimab plus lenvatinib in patients with advanced cervical cancer who progressed after prior immune checkpoint inhibitors: a multicenter, single-arm, phase II trial
中文标题：赛帕利单抗+仑伐替尼治疗ICI经治后病情进展的晚期宫颈癌患者：一项多中心、单臂、II期临床试验
汇报人：蓝春燕丨中山大学肿瘤防治中心
专场标题：Focused Forum II: Improving Cervical Cancer Care: Expanding on What’s Old and Quickly Implementing What’s New (Cervical Cancer Taskforce)
英文标题：Immunotherapy Rechallenge with Cadonilimab in Patients with Recurrent or Metastatic Cervical Cancer: A Retrospective Study
中文标题：复发性或转移性宫颈癌患者再次接受卡度尼利单抗免疫疗法治疗：一项回顾性研究
汇报人：Lin Jie丨福建省肿瘤医院
专场标题：Focused Forum XV: Ongoing IMPACT
英文标题：Biomarker-driven Targeted Therapy in Platinum-Resistant Ovarian Cancer (PROC): Results from the BRIGHT Trial
中文标题：铂类耐药卵巢癌的生物标志物驱动靶向治疗：BRIGHT试验结果
汇报人：高庆蕾丨华中科技大学同济医学院附属同济医院
专场标题：Focused Forum XV: Ongoing IMPACT
英文标题：(ENCORE) An open-label, prospective phase II study of cadonilimab in combination with neoadjuvant chemotherapy for patients diagnosed with advanced ovarian cancer (AK104-IIT-003)
中文标题：ENCORE：一项针对卡度尼利单抗联合新辅助化疗治疗晚期卵巢癌患者的开放标签、前瞻性II期研究（AK104-IIT-003）
汇报人：唐洁丨湖南省肿瘤医院
特色壁报专场（Featured Poster Session）
专场标题：Oral Featured Poster Session II: Multiple Ways to Make an IMPACT
英文标题：AK104 combined with concurrent chemoradiotherapy for the treatment of locally advanced Cervical Cancer
中文标题：AK104联合同期放化疗治疗局部晚期宫颈癌
汇报人：蒋芳丨北京协和医院
专场标题：Oral Featured Poster Session II: Multiple Ways to Make an IMPACT
英文标题：Neoadjuvant Chemotherapy Followed by Chemoradiation Plus Adjuvant Chemotherapy for Locally Advanced Cervical Cancer: A Real-World Study with 10 Years Experience
中文标题：局晚期宫颈癌患者在新辅助化疗后进行放化疗和辅助化疗：一项10年真实世界研究
汇报人：唐洁丨湖南省肿瘤医院
专场标题：Oral Featured Poster Session V: Therapeutic Influences 3-2-1 IMPACT
英文标题：Pamiparib in combination with surufatinib in patients with platinum-resistant ovarian cancer who received prior PARP inhibitors: a multicenter, single-arm, phase Ib/II trial (POST-PARPi Trial)
中文标题：帕米帕利+索凡替尼用于PARPi经治的铂耐药卵巢癌：一项多中心、单臂、Ib/II期POST-PARPi试验
汇报人：蓝春燕丨中山大学肿瘤防治中心
壁报导览（Poster Tour）
专场标题：Poster Tour Group 3: Emerging IMPACT in Clinical Trials and their Methodology
英文标题：Enlonstobart (SG001) plus platinum-based chemotherapy ± bevacizumab for first-line treatment of PD-L1 positive recurrent/metastatic cervical cancer: safety run-in results of the phase III randomized, double-blind trial
中文标题：Enlonstobart (SG001)联合铂类化疗±贝伐珠单抗用于PD-L1阳性复发/转移性宫颈癌的一线治疗：III期随机双盲试验的安全性结果
汇报人：佐晶丨中国医学科学院北京协和医学院
专场标题：Poster Tour Group 14: Clinical Trials IMPACTING Future Therapies
英文标题：Efficacy and safety of carboplatin/paclitaxel combined tislelizumab for recurrent ovarian cancer progressing within 6-12 months after the last platinum line.
中文标题：卡铂/紫杉醇联合替雷利珠单抗治疗末次一线铂类治疗后6-12个月内进展的复发性卵巢癌的疗效和安全性
汇报人：杨谢兰丨云南省肿瘤医院
专场标题：Poster Tour Group 18: IMPACTFUL Clinical Trials: MAbs and Small Molecules
英文标题：Cadonilimab combined with TP regimen-induced cisplatin concurrent radiotherapy for locally advanced cervical cancer: A Prospective, Single-Arm Phase II Clinical Trial
中文标题：卡度尼利单抗联合TP方案诱导的顺铂同步放疗用于局部晚期宫颈癌：一项前瞻性、单臂 Ⅱ 期临床试验
汇报人：李铭仪丨广州医科大学附属肿瘤医院
专场标题：Poster Tour Group 18: IMPACTFUL Clinical Trials: MAbs and Small Molecules
英文标题：Fluzoparib plus apatinib maintenance in patients with platinum-sensitive recurrent ovarian cancer who had received first-line maintenance with a PARP inhibitor (FLASH): A single-arm exploratory trial
中文标题：氟唑帕利+阿帕替尼维持治疗铂敏感复发卵巢癌患者，且该患者已经过PARPi(FLASH)的一线维持治疗：一项单臂探索性试验
汇报人：王金华丨江苏省肿瘤医院
专场标题：Poster Tour Group 18: IMPACTFUL Clinical Trials: MAbs and Small Molecules
英文标题：The safety and efficacy of cadonilimab in advanced, recurrent, or metastatic cervical cancer: A multicenter, prospective, real-world study
中文标题：卡度尼利单抗治疗晚期、复发或转移性宫颈癌的安全性和有效性：一项多中心、前瞻性、真实世界研究
汇报人：Xu Yuanyuan丨河南省肿瘤医院
壁报专场（Poster Session）
摘要ID：819672
英文标题：Efbemalenograstim Alfa for Primary Prophylaxis of Chemotherapy-Induced Neutropenia In Patients With Ovarian and Cervical Cancer: A Single-Arm, Multicenter Clinical Trial
中文标题：艾贝格司亭α注射液用于卵巢癌和宫颈癌患者化疗引起的中性粒细胞减少症的一级预防：一项单臂、多中心临床试验
汇报人：王丽梅丨山东大学齐鲁医院
摘要ID：823810
英文标题：Long-term outcomes of local tumor destruction/excision not inferior to total hysterectomy for stage IA cervical cancer : A retrospective cohort study with propensity score matching analysis
中文标题：IA期宫颈癌进行局部肿瘤消融/切除术的长期结局不劣于全子宫切除术：一项采用倾向评分匹配分析的回顾性队列研究
汇报人：徐沁丨福建省肿瘤医院
摘要ID：837185
英文标题：Anlotinib + penpulimab plus chemo-less therapy in first-line treatment for persistent, recurrent, or metastatic cervical cancer: a single-arm, open-label phase a… study (ALTN-AK105-II-06)
中文标题：安罗替尼 + 派安普利单抗联合无化疗方案用于持续性、复发性或转移性宫颈癌一线治疗：一项单臂、开放标签、Ⅱ期临床研究（ALTN-AK105-II-06）
汇报人：徐沁丨福建省肿瘤医院
摘要ID：819959
英文标题：A nomogram for predicting overall survival in patients with clear cell adenocarcinoma of the cervix: a population-based analysis
中文标题：一种预测宫颈透明细胞腺癌患者总生存期的列线图：基于人群的分析
汇报人：徐沁丨福建省肿瘤医院
摘要ID：828451
英文标题：Anlotinib Enhances Immunotherapy Efficacy in PIK3CA-Mutant Cervical Cancer by Inhibiting RPS26-Mediated Activation of the PI3K/AKT Pathway
中文标题：安罗替尼通过抑制RPS26介导的PI3K/AKT通路激活增强PIK3CA突变宫颈癌的免疫治疗效果
汇报人：徐沁丨福建省肿瘤医院
摘要ID：827266
英文标题：Exploring the Impact of Circulating Inflammatory Proteins on Cervical Cancer Lesion Progression: A Two-Sample Bidirectional Mendelian Randomization Study
中文标题：探索循环炎症蛋白对宫颈癌病变进展的影响：一项双样本双向孟德尔随机化研究
汇报人：徐沁丨福建省肿瘤医院
摘要ID：869961
英文标题：Development and Validation of a Radiomics Nomogram for Metastasis Prediction in Neuroendocrine Carcinoma of the Cervix
中文标题：宫颈神经内分泌瘤的转移预测：放射组学列线图的开发与验证
汇报人：余海娟丨福建省肿瘤医院
摘要ID：841950
英文标题：Comparative Analysis of Laparoscopic versus Open Inguinal Lymphadenectomy in Vulvar Cancer Surgery from Single Cancer Center ten years data
中文标题：外阴癌手术采用腹腔镜 vs 开放腹股沟淋巴结清扫术：癌症单中心十年数据比较分析
汇报人：张正茂丨河北医科大学第四医院&河北省肿瘤医院
摘要ID：831183
英文标题：ALTER-GO-010: A multicenter, single-arm, phase 2 study of anlotinib combined with carboplatin plus paclitaxel and maintenance anlotinib as front-line treatment for newly diagnosed advanced ovarian cancer
中文标题：ALTER-GO-010：一项关于安罗替尼联合卡铂与紫杉醇并以安罗替尼维持治疗作为新诊断晚期卵巢癌一线治疗方案的多中心、单臂、II期研究
汇报人：程文俊丨江苏省人民医院
摘要ID：865356
英文标题：Laparoscopic Pelvic Lymph Node Dissection Plus Open Abdominal Radical hysterectomy
中文标题：腹腔镜盆腔淋巴结清扫术+开腹根治性子宫切除术的研究
汇报人：林洁丨福建省肿瘤医院
摘要ID：827945
英文标题：A novel deep learning model for automatic segmentation in cervical cancer brachytherapy
中文标题：一种用于宫颈癌近距离放射治疗自动分割的新型深度学习模型
汇报人：徐沁丨福建省肿瘤医院
摘要ID：832908
英文标题：Comparison of long-term clinical outcomes between patients with and without neoadjuvant therapy before surgery in stage IB2-IIB cervical cancer: a propensity score-matched study
中文标题：IB2-IIB期宫颈癌患者术前接受和未接受新辅助治疗的长期临床结局比较：倾向评分匹配研究
汇报人：徐沁丨福建省肿瘤医院
摘要ID：823645
英文标题：The impact of the COVID-19 pandemic on the diagnosis, treatment, and prognosis of ovarian cancer in the United States:A retrospective cohort study based on the SEER database
中文标题：COVID-19疫情对美国卵巢癌诊断、治疗及预后的影响：基于SEER数据库的回顾性队列研究
汇报人：徐沁丨福建省肿瘤医院
摘要ID：827261
英文标题：Dynamic Role of Circulating Immune Cells in the Progression of Cervical Malignant Lesion: A Two-sample Mendelian Randomization Study
中文标题：循环免疫细胞在宫颈恶性病变进展中的动态作用：双样本孟德尔随机化研究
汇报人：徐沁丨福建省肿瘤医院
摘要ID：834366
英文标题：Nituzumab plus Serplulimab combined with SBRT in recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial
中文标题：尼妥珠单抗+斯鲁利单抗联合SBRT治疗复发性晚期宫颈癌：一项前瞻性、多中心、单臂、II期临床试验
汇报人：徐沁丨福建省肿瘤医院
摘要ID：827311
英文标题：Lipids, as fundamental components of cells, exert a substantial influence on diverse biological processes. Although significant, their precise impact on cervical cancer development remains largely uncertain.
中文标题：脂质作为细胞的基本组成部分，对多种生物学过程有着重大影响，但其对宫颈癌发展的具体影响仍不确定
汇报人：徐沁丨福建省肿瘤医院
手术展示：APP虚拟展示（Surgical Films: Virtual Display on the App）
英文标题：Minimally invasive total vaginectomy utilizing robotic-assisted minimally invasive surgery and laparoscopic techniques for the management of malignant melanoma in the female reproductive system
中文标题：机器人辅助微创全阴道切除术和腹腔镜技术治疗女性生殖系统恶性黑色素瘤
汇报人：何海新丨福建省肿瘤医院
英文标题：Resection of Ilio-inguinal Mass and Reconstruction with Artificial Vascular Graft in Vulvar Cancer Recurrence after Lymphadenectomy and Radiotherapy
中文标题：外阴癌淋巴结清扫及放疗后复发行髂腹股沟肿物切除术及人工血管移植重建术
汇报人：涂画丨中山大学肿瘤防治中心
如有疏漏，敬请指出。
https://www.sgo.org/events/annual-meeting/am25-schedule/#presentations
排版编辑：肿瘤资讯-zxy
扫描二维码关注专题不迷路！
苏公网安备32059002004080号
